NCT07293338 Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
| NCT ID | NCT07293338 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Dilated Cardiomyopathy (DCM) |
| Study Type | OBSERVATIONAL |
| Enrollment | 330 participants |
| Start Date | 2026-01-06 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 330 participants in total. It began in 2026-01-06 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the long-term prognostic of coronary microvascular dysfuction in Patients with Dilated Cardiomyopathy. The main question it aims to answer is: Does the coronary microvascular dysfunction impact the outcomes in Patients with Dilated Cardiomyopathy.
Eligibility Criteria
Inclusion Criteria: * Dilated cardiomyopathy comfirmed by echocardiography: LVDd \> 55 mm in men or \> 50 mm in women. * Clinically evident congestive heart failure: Compatible symptoms and signs, and BNP ≥ 35 pg/mL or NT-proBNP ≥ 125 pg/mL, and LV systolic dysfunction defined by LVEF \< 45 %. * Coronary angiography showing stenosis ≤ 50 % in all major epicardial vessels. Exclusion Criteria: * Patients with coronary artery disease, hypertensive heart disease, rheumatic valvular heart disease, myocarditis, and other secondary cardiomyopathies. * poor angiographic image quality
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07293338 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dilated Cardiomyopathy (DCM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07293338 currently recruiting?
Yes, NCT07293338 is actively recruiting participants. Contact the research team at 21918219@zju.edu.cn for enrollment information.
Where is the NCT07293338 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07293338 clinical trial?
NCT07293338 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 330 participants.